Compare Johnson & Johnson (JNJ) vs Kroger Co (KR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Kroger Co — how do they compare? Johnson & Johnson trades at $250.83 (market cap $598.96B), while Kroger Co trades at $57.72 (market cap $35.75B). The key difference: Johnson & Johnson is far larger — about 16.8× Kroger Co's market cap, and Kroger Co pays the higher dividend (2.47%). Which is the better fit depends on your goals.
| JNJ | KR | |
|---|---|---|
Market Cap | $598.96B | $35.75B |
Volume | 6,156,228 | — |
Sector | Health | Consumer Staples |
52-Week High | $267.24 | $75.60 |
52-Week Low | $164.36 | $55.53 |
Enterprise Value | $631.90B | $55.85B |
Dividend Yield | 2.15% | 2.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $250.61, down 0.96% on the day, with a bullish technical signal and strong fundamental performance. Recent Q2 2026 earnings beat expectations with EPS of $2.90 versus $2.84 expected, and revenue growth of 6.6% year-over-year. The stock shows robust profitability with a net income margin of 21.48% and ROE of 26.42%, supported by consistent dividend payments including the recent $1.34 per share declared for H1-2026.
JNJ presents a favorable investment case with analyst consensus price target of $279.33 implying ~11% upside, though rising debt-to-asset ratio to 24.06% in 2025 and volatile cash flow trends pose risks. The healthcare giant's diversified portfolio and raised full-year guidance underpin long-term stability, but investors should monitor execution amid competitive and regulatory pressures.
Kroger (KR) trades at $57.78, down 1.77% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a low P/S ratio of 0.25 and improving cash flow, generating $2.08B net cash in 2025. Recent developments include the $1.65B Giant Eagle acquisition expanding Midwest presence and ongoing dividend payments, with analyst consensus pointing to 19% upside to the $68.63 price target.
KR presents a value opportunity with defensive characteristics, trading below analyst targets amid competitive grocery sector pressures. Key risks include margin compression from industry pricing wars and integration challenges from recent acquisitions, while positive catalysts include retail media growth and private label expansion driving long-term shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Kroger Co
Kroger is the leading American grocer, with 2,726 supermarkets operating under several banners throughout the country as of the end of fiscal 2021. Around 83% of stores have pharmacies, while nearly 60% also sell fuel. The company also operates roughly 120 fine jewelry stores. Kroger features a leading private-label offering and manufactures around 30% of its own-brand units (and more than 40% of its grocery own-label assortment) itself, in 33 food production plants nationwide. Kroger is a top-two grocer in most of its major markets (as of early 2021, according to company data). Virtually all of Kroger's sales come from the United States.
Read more on KR →
